Correction: Current outlook on radionuclide delivery systems: From design consideration to translation into clinics (Journal of Nanobiotechnology (2019) 17:1 (90) DOI: 10.1186/s12951-019-0524-9)

Oleksii O. Peltek, Albert R. Muslimov, Mikhail V. Zyuzin, Alexander S. Timin

Результат исследований: Материалы для журналаКомментарий/дискуссия

Аннотация

After publication of this article, an error was found in the description of the holmium isotopes. 165Ho is a stable isotope a fraction of which is activated to 166Ho by neutron activation in a nuclear reactor [2]. In one paragraph of the published article, describing holmium containing QuiremSpheres, 165Ho should be replaced with 166Ho. The correct description is given below. "QuiremSpheres are poly-l-lactic acid based microspheres, containing 166Ho. The size of the particles varies from 15 to 60 µm and the use of poly-l-lactic acid allows to achieve the particle density of 1.4 g/cm3, which is closer to the density of blood (1.06 g/cm3). The 165Ho is activated to 166Ho with neutron activation in a nuclear reactor. Due to the short half-life period of 166Ho, each patient dose of QuiremSpheres needs to be prepared separately, thus, a specific activity can differ in each dose and depends on the needs of a patient".

Язык оригиналаАнглийский
Номер статьи2
ЖурналJournal of Nanobiotechnology
Том18
Номер выпуска1
DOI
СостояниеОпубликовано - 2 янв 2020

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • Applied Microbiology and Biotechnology
  • Pharmaceutical Science

Fingerprint Подробные сведения о темах исследования «Correction: Current outlook on radionuclide delivery systems: From design consideration to translation into clinics (Journal of Nanobiotechnology (2019) 17:1 (90) DOI: 10.1186/s12951-019-0524-9)». Вместе они формируют уникальный семантический отпечаток (fingerprint).

  • Цитировать